Prostamide-containing intraocular implant

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9889142
APP PUB NO 20160199387A1
SERIAL NO

15075922

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Prostamide-containing biodegradable intraocular implants, prostamide compounds, prostamide-containing pharmaceutical compositions, and methods for making and using such implants and compositions for the immediate and sustained reduction of intraocular pressure and treatment of glaucoma in an eye of a patient are described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ALLERGAN, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ambrus, Gyorgy F Santa Ana, US 19 30
Burk, Robert M Laguna Beach, US 198 1724
Dinh, Danny T Costa Mesa, US 38 181
Durairaj, Chandrasekar Lexington, US 5 5
Hughes, Patrick M Aliso Viejo, US 180 4950
Liu, Hui Irvine, US 474 6905
Robinson, Michael R Irvine, US 105 2684
Shen, Jie Irvine, US 134 843
Wan, Jinping Irvine, US 44 380
Woodward, David F Lake Forest, US 154 2065
Wu, Ke Irvine, US 163 806

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 13, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 13, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00